Open Access

P2Y2R has a significant correlation with Notch‑4 in patients with breast cancer

  • Authors:
    • Dong Chul Kim
    • Hana Jin
    • Jong Sil Lee
    • Euna Son
    • Gyeong Won Lee
    • Hye Jung Kim
  • View Affiliations

  • Published online on: May 14, 2020     https://doi.org/10.3892/ol.2020.11630
  • Pages: 647-654
  • Copyright: © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Our previous study found that highly metastatic breast cancer cells, such as MDA‑MB‑231 cells, release higher levels of ATP and exhibit greater P2Y2 receptor (P2Y2R) activity than lowly metastatic breast cancer cells, and that P2Y2R activation mediated by ATP plays a significant role in tumor progression and metastasis. In addition, we reported that radiotherapy‑resistant (RT‑R) breast cancer cells promote invasion and tumor growth through the activation of P2Y2R by ATP released from RT‑R‑breast cancer cells than breast cancer cells. Moreover, increased numbers of cancer stem cells (CSCs) were observed among the RT‑R‑breast cancer cell population. Therefore, in this study, we investigated the expression level of five CSC markers (CD24, CD44, Oct3/4, Notch‑4 and ALDH1A1) as well as P2Y2R in the tumor tissues of patients with breast cancer and determined which CSC marker correlates with P2Y2R in breast cancer. According to the immunohistochemical analysis, CD44, Oct3/4 and Notch‑4 but not ALDH1A1 were significantly expressed in the tumor tissues (n=180) compared with the normal epithelial tissues (n=20) of patients with breast cancer. It was demonstrated that P2Y2R expression was increased in tumor tissues of patients with breast cancer compared with normal epithelial tissue. Notably, it was identified that P2Y2R expression has a significant correlation with only the CSC marker Notch‑4 in patients with breast cancer. The results of this study suggested for the first time to the best of our knowledge that Notch‑4 has a notable correlation with P2Y2R, which has important roles in tumor progression and metastasis.

Related Articles

Journal Cover

July 2020
Volume 20 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Kim, D.C., Jin, H., Lee, J.S., Son, E., Lee, G.W., & Kim, H.J. (2020). P2Y2R has a significant correlation with Notch‑4 in patients with breast cancer. Oncology Letters, 20, 647-654. https://doi.org/10.3892/ol.2020.11630
MLA
Kim, D. C., Jin, H., Lee, J. S., Son, E., Lee, G. W., Kim, H. J."P2Y2R has a significant correlation with Notch‑4 in patients with breast cancer". Oncology Letters 20.1 (2020): 647-654.
Chicago
Kim, D. C., Jin, H., Lee, J. S., Son, E., Lee, G. W., Kim, H. J."P2Y2R has a significant correlation with Notch‑4 in patients with breast cancer". Oncology Letters 20, no. 1 (2020): 647-654. https://doi.org/10.3892/ol.2020.11630